Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis [Phase 1, Phase 2]
A clinical trial update on fecal microbiota transplantation for ulcerative colitis spanning Phase 1 and Phase 2, completed.
-
FDA approval · 2018-10-16FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Optimization of Golimumab Treatment in Ulcerative Colitis [Phase 4]
Phase 4 clinical trial update on optimizing golimumab treatment for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of Mongersen (GED-0301) in subjects with active ulcerative colitis has completed wit…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). [Phase 4]
Phase 4 clinical trial update evaluating the correlation between soluble ST2 and response to Golimumab (MK-8259) in ulcerative colitis parti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis [Phase 3]
Phase 3 trial comparing azathioprine with allopurinol versus standard azathioprine therapy for ulcerative colitis, evaluating beneficial and…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial update for TP05 in mild to moderate active ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) [Phase 3]
Phase 3 trial update for an oral ferric iron therapy in iron deficiency anaemia associated with ulcerative colitis, with completed status an…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases
A completed clinical trial examined cannabinoid receptor expression in gastrointestinal diseases. The study covered ulcerative colitis, Croh…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 [Phase 1]
This is a Phase 1 single-dose escalation trial of GSK3050002 to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics in ulc…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Immunonutrition in Ulcerative Colitis [NA]
This document reports an update on a clinical trial investigating immunonutrition for ulcerative colitis, sponsored by Baptist Memorial Heal…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Thermography in Surveillance of Ulcerative Colitis
A completed clinical trial evaluating thermography as a surveillance tool in ulcerative colitis.
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis [NA]
A completed clinical trial evaluating the utility of second-generation colon capsule endoscopy for ulcerative colitis, sponsored by the Chin…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients [Phase 2]
Phase 2 clinical trial evaluating capsulized fecal microbiota transplantation for pediatric ulcerative colitis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis [EARLY_Phase 1]
This early-phase 1 trial from the University of Vermont investigates fecal microbiota transplant for active moderate Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC)
A completed clinical trial evaluated indicators that predict the need for surgery in patients with acute severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
The update reports long-term safety data from a completed trial evaluating infliximab (Remicade) in patients with ulcerative colitis.
-
FDA approval · 2018-07-03FDA Approved: BUDESONIDE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for Budesonide from Actavis Pharma, Inc. (ANDA205457).
-
FDA approval · 2018-06-26FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Mesalamine from Zydus Lifesciences Limited, resulting in updated labeling for the drug.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
A completed clinical trial update notes sub-optimal responses to anti-TNF therapies in inflammatory bowel disease, including ulcerative coli…
-
FDA approval · 2018-06-08FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
FDA approval · 2018-05-30FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS research · 2018-05-25Clinical Trial Update: TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis [NA]
This clinical trial entry compares TAMIS-IPAA vs Lap-IPAA for ulcerative colitis, sponsored by Jinling Hospital, with the trial status liste…
-
FDA approval · 2018-05-23FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIALDA (mesalamine) submitted by Takeda Pharmaceuticals America, Inc., to update the product…
-
FDA approval · 2018-05-23FDA Approved: MERCAPTOPURINE — Supplemental Application (Florida Pharmaceutical Products, LLC)
The FDA approved a supplemental application for mercaptopurine from Florida Pharmaceutical Products, LLC.